始立: Difference between revisions
From SEHK Wiki
Created page with "Category: 多巴胺能抗柏金遜藥物 '''口服抗柏金遜藥物''' '''藥物類別：:Category: 多巴胺能抗柏金遜藥物 |..." |
No edit summary |
||
| Line 6: | Line 6: | ||
'''左旋多巴和卡比多巴''' (English: [[Sinemet | Levodapa and Carbidopa (Sinemet)]]) | '''左旋多巴和卡比多巴''' (English: [[Sinemet | Levodapa and Carbidopa (Sinemet)]]) | ||
==常見劑量== | |||
Revision as of 04:51, 14 October 2024
藥物類別： 多巴胺能抗柏金遜藥物，並被歸類為 去羧酶抑制劑和 兒茶酚-O-甲基轉移酶（COMT）抑制劑的組合
左旋多巴和卡比多巴 (English: Levodapa and Carbidopa (Sinemet))
